Type‐1‐diabetic mice subcutaneously implanted with microencapsulated HEAT‐transgenic insulin‐producing cells and equipped with heating patches showed continued hyperglycemia without any improvement of their diabetic state when the patch remained switched off, suggesting that the engineered cells do not show any physiologically relevant leakiness (Figure 4c). This evidence concerns the gene INS and Hyperglycemia.